FARMAKOKINETIKA VA FARMAKODINAMIKANING DORILARNI ISHLAB CHIQARISHGA TA’SIRI
Том 4 № 62 (2026) 141-147
Аннотация
Ключевые слова:
Библиографические ссылки
Rang, H. P., Dale, M. M., Ritter, J. M., Flower, R. J., & Henderson, G. (2019). Rang & Dale’s Pharmacology. Elsevier.
Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2018). Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. McGraw-Hill.
European Medicines Agency. (2023). Guidelines on Pharmacokinetics and Pharmacodynamics in Drug Development. EMA.
U.S. Food and Drug Administration. (2024). Clinical Pharmacology Considerations for Drug Development and Approval. FDA.
Katzung, B. G. (2021). Basic and Clinical Pharmacology. McGraw-Hill.
Shargel, L., Yu, A. B. C., & Wu-Pong, S. (2016). Applied Biopharmaceutics & Pharmacokinetics. McGraw-Hill Education.
Rowland, M., & Tozer, T. N. (2019). Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications. Wolters Kluwer.
Gabrielsson, J., & Weiner, D. (2016). Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications. Swedish Pharmaceutical Press.
Derendorf, H., & Meibohm, B. (1999). Modeling of pharmacokinetic/pharmacodynamic relationships: Concepts and perspectives. Pharmaceutical Research, 16(2), 176–185.
Benet, L. Z. (2013). Pharmacokinetics: Basic principles and its use as a tool in drug metabolism. Drug Metabolism Reviews, 45(1), 1–5.
География читателей
Загрузки
Опубликован
Выпуск
Раздел
Лицензия
Copyright (c) 2026 Innovative Academy RSC

Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Как цитировать